Authors: FEUSSNER G FEUSSNER V HOFFMANN MM LOHRMANN J WIELAND H MARZ W

Citation: G. Feussner et al., MOLECULAR-BASIS OF TYPE-III HYPERLIPOPROTEINEMIA IN GERMANY, Human mutation, 11(6), 1998, pp. 417-423

Authors: EICHINGER M LOHRMANN J FEUSSNER V FEUSSNER G

Citation: M. Eichinger et al., SIGNIFICANTLY DECREASED FREQUENCY OF A COMMON MUTATION IN THE METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) GENE IN PATIENTS WITH TYPE-III HYPERLIPOPROTEINEMIA (HLP), Atherosclerosis, 134(1-2), 1997, pp. 67-67

Authors: FEUSSNER G FEUSSNER V LOHRMANN J HOFFMANN MM WIELAND H MARZ W

Citation: G. Feussner et al., MOLECULAR-BASIS OF TYPE-III HYPERLIPOPROTEINEMIA (HLP), Atherosclerosis, 134(1-2), 1997, pp. 67-67

Authors: FEUSSNER G FEUSSNER V ZIEGLER R

Citation: G. Feussner et al., APOLIPOPROTEIN (A) PHENOTYPES AND LIPOPROTEIN (A) CONCENTRATIONS IN PATIENTS WITH TYPE-III HYPERLIPOPROTEINEMIA, Journal of internal medicine, 235(5), 1994, pp. 425-430

Authors: FEUSSNER G FEUSSNER V BOMMER J GRUTZMACHER P ZIEGLER R

Citation: G. Feussner et al., TYPE-III HYPERLIPOPROTEINEMIA AND RENAL-DISEASE, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 4(2), 1994, pp. 96-100

Authors: FEUSSNER G FEUSSNER V ZIEGLER R

Citation: G. Feussner et al., LIPOPROTEIN(A) [LP(A)] - A GENETIC RISK F ACTOR FOR ARTERIOSCLEROSIS, Medizinische Klinik, 89(4), 1994, pp. 198-203